FI956178A0 - Varsibromelaiiniproteaasin lääkekäyttö - Google Patents

Varsibromelaiiniproteaasin lääkekäyttö

Info

Publication number
FI956178A0
FI956178A0 FI956178A FI956178A FI956178A0 FI 956178 A0 FI956178 A0 FI 956178A0 FI 956178 A FI956178 A FI 956178A FI 956178 A FI956178 A FI 956178A FI 956178 A0 FI956178 A0 FI 956178A0
Authority
FI
Finland
Prior art keywords
shaft
medical use
bromelain protease
bromelain
protease
Prior art date
Application number
FI956178A
Other languages
English (en)
Swedish (sv)
Other versions
FI956178A (fi
Inventor
Tracey Lehanne Mynott
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of FI956178A0 publication Critical patent/FI956178A0/fi
Publication of FI956178A publication Critical patent/FI956178A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
FI956178A 1993-06-25 1995-12-21 Varsibromelaiiniproteaasin lääkekäyttö FI956178A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313188A GB9313188D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes
PCT/GB1994/001368 WO1995000169A1 (en) 1993-06-25 1994-06-24 Medical use of stem bromelain protease

Publications (2)

Publication Number Publication Date
FI956178A0 true FI956178A0 (fi) 1995-12-21
FI956178A FI956178A (fi) 1996-02-21

Family

ID=10737823

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956178A FI956178A (fi) 1993-06-25 1995-12-21 Varsibromelaiiniproteaasin lääkekäyttö

Country Status (11)

Country Link
US (1) US5824305A (fi)
EP (1) EP0713396A1 (fi)
JP (1) JPH08511687A (fi)
AU (1) AU681891B2 (fi)
CA (1) CA2165787A1 (fi)
FI (1) FI956178A (fi)
GB (1) GB9313188D0 (fi)
NO (1) NO955258L (fi)
NZ (1) NZ267660A (fi)
SG (1) SG42309A1 (fi)
WO (1) WO1995000169A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
AU6303898A (en) 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
EP1096951B1 (de) 1998-07-15 2002-08-14 URSAPHARM Arzneimittel GmbH & Co. KG Verwendung von bromelainproteasen zur hemmung der blutgerinnung
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
EP1942930A2 (en) * 2005-10-11 2008-07-16 Amano Enzyme USA., Ltd. Enzyme inhibitors of pai-1
EP2036978A1 (en) * 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions
JP6952353B2 (ja) 2016-01-31 2021-10-20 メディウーンド リミテッド 創傷を治療するためのデブリードマン組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197291A (en) * 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
GB8821049D0 (en) * 1988-09-08 1988-10-05 Health Lab Service Board Method & composition for treatment & prevention of viral infections
HUT67007A (en) * 1991-07-24 1995-01-30 Enzacor Pty Ltd Preparations containing biologically activ agent wich are absorbed in the superior intestinal tract of animals
NZ253748A (en) * 1992-06-30 1997-06-24 Cortecs Ltd Use of enzymes especially proteolytic enzymes in the management or treatment of diarrhoea

Also Published As

Publication number Publication date
CA2165787A1 (en) 1995-01-05
NZ267660A (en) 1997-05-26
WO1995000169A1 (en) 1995-01-05
JPH08511687A (ja) 1996-12-10
NO955258D0 (no) 1995-12-22
NO955258L (no) 1996-02-22
AU7002794A (en) 1995-01-17
EP0713396A1 (en) 1996-05-29
US5824305A (en) 1998-10-20
GB9313188D0 (en) 1993-08-11
FI956178A (fi) 1996-02-21
SG42309A1 (en) 1997-08-15
AU681891B2 (en) 1997-09-11

Similar Documents

Publication Publication Date Title
BR9407685A (pt) Combinaçoes de elastômeros inter-vulcanizados
DE69415068D1 (de) Mikromotor und Herstellungsverfahren desselben
DE69434376D1 (de) Videotrainingsverfahren und display
FI943234A0 (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
DE69815833D1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
FI953281A (fi) Vaippa- tai sisäosatyypin absorboiva tuote
FI965204A (fi) Bromelaiinin lääkekäyttö
NO971900D0 (no) Blandinger og behandling av multippel sklerose
FI956178A (fi) Varsibromelaiiniproteaasin lääkekäyttö
DE69434084D1 (de) Diagnostische anwendungen von hydrazinoadenosine
DE69433215D1 (de) Medizinische Spritze
NO963482D0 (no) Medisinsk anvendelse av bromelain
GB9526691D0 (en) Medical use of proteases
FR2735693B1 (fr) Nouvelles applications therapeutiques de n-cyclohexyl benzamides
NO931399D0 (no) Anvendelse av naturstein
BR9608978A (pt) Inibidor de protease de serina derivado de imidazo [1,5a] piridina composição farmacêutica e utilização do inibidor de protease
DE69400232T2 (de) Elastische Wellenkupplung
KR950013311U (ko) 식기세척기의 표시장치
NO944839D0 (no) Anvendelse av vismut
ID15808A (id) Penggunaan protease dibidang kedokteran
SE9301995D0 (sv) Ny medicinsk anvaendning
DE9320587U1 (de) Gelenkbandage
KR950013629U (ko) 제함기의 제함장치
LV10034A (lv) Miksto audu proteze
NO930457D0 (no) Pakking av baller